Euan Ashley
Professor, Genomics & Precision Health
Stanford
Molly He
CEO
Element Bioscience
Alex Aravanis
CTO
Illumina
Sarah Hersey
VP, Precision Medicine
Bristol Myers Squibb
Bruce J. Tromberg
Director
National Institute of Biomedical Imaging and Bioengineering, NIH
Mara Aspinall
Managing Director
BlueStone Venture Partners
Stephen F. Kingsmore
President & CEO
Rady Children’s Institute for Genomic Medicine
Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center
Eric Dishman
Former Director, All of Us Research Program
NIH
Alicyn Campbell
Head, Digital Health Oncology
AstraZeneca
Christopher M. Hartshorn
Chief, Digital & Mobile Technologies
NCATS, NIH
Razelle Kurzrock
Chair, Clinical Trials Committee
WIN for Personalized Cancer Therapy
Howard I. Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center
Jacqueline Shreibati
Senior Clinical Lead, Consumer Health
Google
Tom Miller
Managing Partner
GreyBird Ventures
Lourdes Barrera
Executive Director, Precision Medicine
Merck
Philip E. Castle
Director, Cancer Prevention
NCI, NIH
Hoi-Ying Elsie Yu
Director, Point-of-Care Testing
Geisinger Health System
Nathan Ledeboer
Vice Chair, Pathology
Medical College of Wisconsin
Michael Snyder
Director, Genomics & Personalized Medicine
Stanford University
Edward Abrahams
President
Personalized Medicine Coalition
Marielena Mata
Diagnostic Lead, Oncology
Pfizer
Christopher Conn
Global Director, Diagnostics Strategy
Amgen
Larry Kessler
Deputy Chair
MCED Consortium
Kenna R. Mills-Shaw
Executive Director, Personalized Cancer Therapy
MD Anderson Cancer Center
Dave Persing
CSO, Cepheid
CSO, Danaher Diagnostics
Cindy Perettie
Head
Roche Molecular Labs
William G. Morice II
CEO
Mayo Clinic Laboratories
Robert J. Bujarski
President and COO
QuidelOrtho
Jay Wohlgemuth
CMO
Quest Diagnostics